Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Mycoses|June 1, 1994
Itraconazole in the treatment of aspergillosis: a study of 16 casesB Lebeau, H Pelloux, C Pinel, et al.
British Journal of Haematology|May 1, 1989
Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trialJ Reiffers, M H Gaspard, D Maraninchi, et al.
Leukemia|July 30, 2003
Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantationN-C Gorin, M Labopin, E Polge, et al.
Bone Marrow Transplantation|July 23, 1998
Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiationM Michallet, F Persat, N Kranzhöfer, et al.
Leukemia|April 15, 2005
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysisP Dreger, R Brand, D Milligan, et al.
Analytical and Quantitative Cytology|March 1, 1982
Non-Hodgkin's malignant lymphomas: a cytologic classification based on statistical analysis and correlated with prognosisJ J Sotto, P Caillot, M F Sotto, et al.
Transplantation Proceedings|December 16, 2014
Short-term pharmacokinetic study of mycophenolate mofetil in neonatal swineH Pan, A Gazarian, A Fourier, et al.
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Leukemia|May 17, 2003
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioningP Dreger, R Brand, J Hansz, et al.
Bone Marrow Transplantation|March 10, 2005
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)A S Michallet, F Nicolini, S Fürst, et al.
Pageof 16